Seeking Alpha05/11/2026 06:15:28

RYAM targets strategic review conclusion in Q1 2027 as Temiscaming carrying costs run $2M-$3M per month

RYAM targets strategic review conclusion in Q1 2027 as Temiscaming carrying costs run $2M-$3M per month

1 hour ago
View Original Source
Seeking Alpha

Seeking Alpha

Seeking Alpha is the leading platform for investors to research and discuss US-traded stocks and ETFs. Our platform helps investors to find successful investing ideas and to successfully manage their portfolios. It provides investment ideas, analysis, news, ratings, investing tools and community discussion.

More from Seeking Alpha

Rapid7 targets ~$130M 2026 free cash flow while planning first generally available autonomous SOC release around RSAC 2027

11 min ago

Bruker expects FY 2026 non-GAAP EPS of $2.10-$2.15 while targeting 250-300 bps operating margin expansion

11 min ago

Solvay SA (SLVYY) Q3 2026 Earnings Call Transcript

12 min ago

Bruker Corporation (BRKR) Q3 2026 Earnings Call Transcript

12 min ago